Naproxen is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is Naproxen.
Product ID | 68788-7072_2ad69b73-b72b-4cc7-b17b-eab743c2ef4a |
NDC | 68788-7072 |
Product Type | Human Prescription Drug |
Proprietary Name | Naproxen |
Generic Name | Naproxen |
Dosage Form | Tablet, Delayed Release |
Route of Administration | ORAL |
Marketing Start Date | 2018-01-02 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA075227 |
Labeler Name | Preferred Pharmaceuticals Inc. |
Substance Name | NAPROXEN |
Active Ingredient Strength | 375 mg/1 |
Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-01-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA075227 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-01-02 |
Marketing Category | ANDA |
Application Number | ANDA075227 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-01-02 |
Marketing Category | ANDA |
Application Number | ANDA075227 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-01-02 |
Marketing Category | ANDA |
Application Number | ANDA075227 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-11-01 |
Marketing Category | ANDA |
Application Number | ANDA075227 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-01-02 |
Marketing Category | ANDA |
Application Number | ANDA075227 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-01-02 |
Ingredient | Strength |
---|---|
NAPROXEN | 375 mg/1 |
SPL SET ID: | 9a13b256-ca82-4f7d-a8ea-a59c60703e92 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |